BACKGROUND. Borrelia burgdorferi, which causes Lyme disease, is transmitted by deer ticks (lxodes dammini) in the northeastern and midwestern United States. Although deer-tick bites are common in areas in which the disease is endemic, there is uncertainty about how to manage the care of persons who are bitten. METHODS. To assess the risk of infection with B. burgdorferi and the efficacy of prophylactic antimicrobial treatment after a deer-tick bite, we conducted a double-blind, placebo-controlled trial in an area of southeastern Connecticut in which Lyme disease is endemic. Children and adults who had been bitten by deer ticks were randomly assigned to receive either amoxicillin or placebo for 10 days. Subjects were followed for one year for clinical manifestations of Lyme disease. Serum samples obtained at enrollment and six weeks and three months later were tested for antibodies against B. burgdorferi. RESULTS. Of the 387 subjects, 205 (53 percent) were assigned to receive amoxicillin and 182 (47 percent) to receive placebo. Of 344 deer ticks submitted and analyzed by the polymerase chain reaction, 15 percent were infected with B. burgdorferi. Erythema migrans developed in two subjects, both of whom had received placebo. There were no asymptomatic seroconversions and no late manifestations of Lyme disease. The risk of infection with B. burgdorferi in the placebo-treated subjects was 1.2 percent (95 percent confidence interval, 0.1 to 4.1 percent), which was not significantly different (P = 0.22) from the risk in the amoxicillin-treated subjects (0 percent; 95 percent confidence interval, 0 to 1.5 percent). CONCLUSIONS. Even in an area in which Lyme disease is endemic, the risk of infection with B. burgdorferi after a recognized deer-tick bite is so low that prophylactic antimicrobial treatment is not routinely indicated.
Source Information
Department of Pediatrics, Yale University School of Medicine, New Haven, Conn. 06510-8064.
This article has been cited by other articles:
Zeidner, N. S., Brandt, K. S., Dadey, E., Dolan, M. C., Happ, C., Piesman, J.
(2004). Sustained-Release Formulation of Doxycycline Hyclate for Prophylaxis of Tick Bite Infection in a Murine Model of Lyme Borreliosis. Antimicrob. Agents Chemother.
48: 2697-2699
[Abstract][Full Text]
Hayes, E. B., Piesman, J.
(2003). How Can We Prevent Lyme Disease?. NEJM
348: 2424-2430
[Full Text]
Rathore, M. H., Barton, L. L.
(2001). Doxycycline Prophylaxis for Lyme Disease. AAP Grand Rounds
6: 14-15
[Full Text]
Nadelman, R. B., Nowakowski, J., Fish, D., Falco, R. C., Freeman, K., McKenna, D., Welch, P., Marcus, R., Aguero-Rosenfeld, M. E., Dennis, D. T., Wormser, G. P., the Tick Bite Study Group,
(2001). Prophylaxis with Single-Dose Doxycycline for the Prevention of Lyme Disease after an Ixodes scapularis Tick Bite. NEJM
345: 79-84
[Abstract][Full Text]
Steere, A. C.
(2001). Lyme Disease. NEJM
345: 115-125
[Full Text]
Feder, H. M., MD, J.
(2000). Lyme Disease Vaccine: Good for Dogs, Adults, and Children?. Pediatrics
105: 1333-1334
[Full Text]
Thanassi, W. T., Schoen, R. T.
(2000). The Lyme Disease Vaccine: Conception, Development, and Implementation. ANN INTERN MED
132: 661-668
[Abstract][Full Text]
Committee on Infectious Diseases,
(2000). Prevention of Lyme Disease. Pediatrics
105: 142-147
[Abstract][Full Text]
Elston, D. M., Edlow, J. A., Horowitz, H., Kilchevsky, E.
(1998). Perinatal Transmission of Human Granulocytic Ehrlichiosis. NEJM
339: 1941-1943
[Full Text]
Bransfield, R. C., Hassler, D., Maiwald, M., Petney, T. N., Piras, M. A., Porqueddu, E. M., Porcu, P., Aceti, A., Anderson, R. E., Fix, A. D., Strickland, G. T., Barbour, A. G.
(1998). Diagnosis, Treatment, and Prevention of Lyme Disease. JAMA
280: 1049-1051
[Full Text]
Shapiro, E. D.
(1998). Lyme Disease. Pediatr. Rev.
19: 147-154
[Full Text]
Fix, A. D., Strickland, G. T., Grant, J.
(1998). Tick Bites and Lyme Disease in an Endemic Setting: Problematic Use of Serologic Testing and Prophylactic Antibiotic Therapy. JAMA
279: 206-210
[Abstract][Full Text]
Barbour, A. G.
(1998). Expert Advice and Patient Expectations: Laboratory Testing and Antibiotics for Lyme Disease. JAMA
279: 239-240
[Full Text]
Feder, H. M. Jr, Hunt, M. S.
(1995). Pitfalls in the Diagnosis and Treatment of Lyme Disease in Children. JAMA
274: 66-68
[Abstract]
Eppes, S. C., Klein, J. D., Caputo, G. M., Rose, C. D.
(1994). Physician Beliefs, Attitudes, and Approaches Toward Lyme Disease in an Endemic Area. CLIN PEDIATR
33: 130-134
[Abstract]
Ley, C., Le, C., Olshen, E. M., Reingold, A. L.
(1994). The Use of Serologic Tests for Lyme Disease in a Prepaid Health Plan in California. JAMA
271: 460-463
[Abstract]
Spach, D. H., Liles, W. C., Campbell, G. L., Quick, R. E., Anderson, D. E., Fritsche, T. R.
(1993). Tick-Borne Diseases in the United States. NEJM
329: 936-947
[Full Text]
Genter, J., Berman, N. G., Madison, R. E., Drachman, D. A., Magid, D., Schwartz, B. S., Craft, J., Schwartz, J. S., Liegner, K. B., Shapiro, E. D., Berg, A. T., Gerber, M. A., Feder, H. M.
(1993). Antimicrobial Prophylaxis after Tick Bites. NEJM
328: 1418-1420
[Full Text]
(1992). ANTI-LYME PROPHYLAXIS HAS NO CLEAR VALUE AFTER TICK BITES. JWatch General
1992: 4-4
[Full Text]
